AbbVie | 8-K: AbbVie Inc. Guidance Including the Impact of Acquired IPR&D and Milestones Expense
Apr 3 16:12 ET
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J
Apr 2 17:08 ET
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Quaggin Susan E
Apr 2 17:08 ET
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director RAPP EDWARD J
Apr 2 17:07 ET
AbbVie | PX14A6G: Notice of exempt solicitation
Apr 2 16:09 ET
AbbVie | PX14A6G: Notice of exempt solicitation
Mar 26 14:35 ET
AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Donoghoe Nicholas
Mar 22 17:03 ET
AbbVie | 144/A: Others
Mar 21 14:32 ET
AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 20 19:33 ET
AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Stewart Jeffrey Ryan
Mar 20 17:03 ET
AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 18 17:07 ET
AbbVie | ARS: Annual Report to Security Holders
Mar 18 16:30 ET
AbbVie | DEF 14A: Definitive information statements
Mar 18 16:23 ET
AbbVie | DEFA14A: Others
Mar 18 16:22 ET
AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer RICHMOND TIMOTHY J.
Mar 5 17:34 ET
AbbVie | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Mar 4 17:25 ET
AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 1 19:55 ET
AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Reents Scott T
Mar 1 17:55 ET
AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Buckbee Kevin K
Mar 1 17:55 ET
AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Michael Robert A.
Mar 1 17:55 ET
No Data
No Data